HighMark Wealth Management »

Eagle Pharmaceuticals shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.2k 2.2k 3.73

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Paragon 28 (FNA)
Performant Finl (PFMT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
AtriCure (ATRC)
Apple (AAPL)

View all positions for HighMark Wealth Management

Top funds holding Eagle Pharmaceuticals

Nantahala Capital Management
AIGH Capital Management
Citigroup
Vanguard Group
AQR Capital Management
BlackRock
Morgan Stanley
BlackRock
Renaissance Technologies
Two Sigma Advisers
Marshall Wace
J. Goldman & Co
Assenagon Asset Management
Two Sigma Investments
Jacobs Levy Equity Management

View all funds holding Eagle Pharmaceuticals